Anlotinib combined with pemetrexed as a further treatment of patients with platinum-resistant ovarian cancer: A single-arm, open-label, phase II studyJueming Chen, Yanna Zhang, Lie Zheng et al.|Gynecologic Oncology|2021Cited by 2